Nucleus of the Optic Tract (NOT) Neurons

Nucleus of the Optic Tract (NOT) Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus of the Optic Tract (NOT) Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0002614](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002614)</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>GABAergic projection neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Pretectal area, dorsal midbrain</td>
</tr>
<tr>
<td class="label">Input</td>
<td>Retina, visual cortex, vestibular nuclei</td>
</tr>
<tr>
<td class="label">Output</td>
<td>Vestibular nuclei, reticulospinal tracts</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>GABA (inhibitory)</td>
</tr>
<tr>
<td class="label">Marker Genes</td>
<td>GAD1, GAD2, GAT1, Calbindin (CALB1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">GAD1</td>
<td>High</td>
</tr>
<tr>
<td class="label">GAD2</td>
<td>High</td>
</tr>
<tr>
<td class="label">GAT1</td>
<td>High</td>
</tr>
<tr>
<td class="label">CALB1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">SLC6A13</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">GABRA1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">PPP1R1B (DARPP-32)</td>

...

Nucleus of the Optic Tract (NOT) Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus of the Optic Tract (NOT) Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0002614](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002614)</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>GABAergic projection neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Pretectal area, dorsal midbrain</td>
</tr>
<tr>
<td class="label">Input</td>
<td>Retina, visual cortex, vestibular nuclei</td>
</tr>
<tr>
<td class="label">Output</td>
<td>Vestibular nuclei, reticulospinal tracts</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>GABA (inhibitory)</td>
</tr>
<tr>
<td class="label">Marker Genes</td>
<td>GAD1, GAD2, GAT1, Calbindin (CALB1)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">GAD1</td>
<td>High</td>
</tr>
<tr>
<td class="label">GAD2</td>
<td>High</td>
</tr>
<tr>
<td class="label">GAT1</td>
<td>High</td>
</tr>
<tr>
<td class="label">CALB1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">SLC6A13</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">GABRA1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">PPP1R1B (DARPP-32)</td>
<td>Low</td>
</tr>
</table>

Introduction

Nucleus Of The Optic Tract (Not) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The Nucleus of the Optic Tract (NOT) is a pretectal nucleus located in the midbrain that plays a critical role in horizontal gaze holding, optokinetic nystagmus (OKN), and vestibular-ocular reflex (VOR) modulation. The NOT is essential for stabilizing images on the retina during head and body movements, making it a key structure for smooth pursuit eye movements. [@basso2017]

This cell type is particularly relevant to neurodegenerative diseases due to its involvement in oculomotor control, which is frequently affected in conditions like Progressive Supranuclear Palsy (PSP), Parkinson's Disease (PD), and Multiple System Atrophy (MSA). [@pierrotdeseilligny2006]

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: neuron of the substantia nigra (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

External Database Links

• [Cell Ontology (CL:0002614)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0002614)
• [OBO Foundry (CL:0002614)](http://purl.obolibrary.org/obo/CL_0002614)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Overview

The Nucleus of the Optic Tract (NOT) is a pretectal nucleus located in the midbrain that plays a critical role in horizontal gaze holding, optokinetic nystagmus (OKN), and vestibular-ocular reflex (VOR) modulation. The NOT is essential for stabilizing images on the retina during head and body movements, making it a key structure for smooth pursuit eye movements. [@glickstein1988]

The Nucleus of the Optic Tract (NOT) is a pretectal nucleus located in the midbrain that plays a critical role in horizontal gaze holding, optokinetic nystagmus (OKN), and vestibular-ocular reflex (VOR) modulation. The NOT is essential for stabilizing images on the retina during head and body movements, making it a key structure for smooth pursuit eye movements. [@leigh2015]

Morphology and Markers

The NOT contains medium-sized GABAergic neurons with elongated dendritic fields oriented perpendicular to the horizontal plane. These neurons receive direct input from the retina and visual cortex, integrating motion signals to modulate eye movements through projections to the vestibular nuclei and brainstem reticular formation.

Normal Function

The NOT serves as a critical node in the oculomotor pathway for horizontal eye movements:

Optokinetic Nystagmus (OKN): Processes visual motion information from the entire visual field to generate slow-phase eye movements that跟踪 moving objects

Smooth Pursuit: Coordinates with the frontal eye fields and cerebellar flocculus for predictive eye tracking

Gaze Stabilization: Maintains visual fixation during self-motion through VOR-OKN integration

Signal Integration: Receives and integrates inputs from:

• Retina (direct and indirect via visual cortex)
• Vestibular nuclei (head velocity signals)
• Cerebellar flocculus (smooth pursuit commands)
• Superior colliculus (saccade suppression)

The NOT projects bilaterally to the vestibular nuclei (particularly the medial and superior vestibular nuclei), which then drive the ocular motor nuclei to generate compensatory eye movements.

Vulnerability in Disease

Progressive Supranuclear Palsy (PSP)

The NOT shows significant vulnerability in PSP due to its involvement in vertical gaze and the progressive degeneration of pretectal and brainstem structures. Patients with PSP exhibit:

• Early impairment of horizontal saccades
• Reduced optokinetic nystagmus
• Gaze palsy affecting both horizontal and vertical planes
• Reduced gain for smooth pursuit

Parkinson's Disease (PD)

In Parkinson's disease, the NOT contributes to:

• Saccadic hypometria (reduced saccade amplitude)
• Impaired smooth pursuit initiation
• Visual processing deficits correlating with disease severity
• Reduced optokinetic response sensitivity

Multiple System Atrophy (MSA)

MSA with cerebellar features (MSA-C) shows:

• NOT dysfunction contributing to oculomotor abnormalities
• Impaired vestibular integration
• Ataxic eye movements ( saccadic pursuit, gaze-evoked nystagmus)

Other Disorders

• Stroke: Lateral medullary syndrome (Wallenberg) affecting vestibular inputs to NOT
• Brain tumors: Pretectal tumors causing Parinaud's syndrome
• Demyelinating disease: Multiple sclerosis plaques affecting NOT circuits

Transcriptomic Profile

Single-cell transcriptomic studies from the Allen Brain Atlas indicate the NOT expresses:

Therapeutic Implications

Deep Brain Stimulation (DBS)

While the NOT is not a primary DBS target, understanding its function is important for:

• Optimizing stimulation parameters for STN/GPi DBS to minimize eye movement side effects
• Predicting post-operative oculomotor outcomes

Pharmacological Approaches

• GABAergic agents: May modulate NOT activity but have limited therapeutic application
• Vestibular rehabilitative therapy: Can help compensate for NOT-mediated gaze stabilization deficits

Biomarker Potential

Oculomotor parameters including OKN gain, smooth pursuit accuracy, and saccade metrics may serve as:

• Early biomarkers for brainstem involvement in neurodegenerative diseases
• Progression markers for PSP and PD
• Outcome measures in clinical trials

See Also

• [Brainstem - Brain region containing NOT
• Superior Colliculus - Related oculomotor structure
• Vestibular Nuclei - Primary NOT output target
• Progressive Supranuclear Palsy - Disease with NOT involvement
• [Parkinson's Disease](/diseases/parkinsons-disease) Disease with oculomotor dysfunction

](/brain-regions/brainstem---brain-region-containing-not
--superior-colliculus---related-oculomotor-structure
--vestibular-nuclei---primary-not-output-target
--progressive-supranuclear-palsy---disease-with-not-involvement
--parkinson's-disease---disease-with-oculomotor-dysfunction)## External Links

• [Allen Brain Atlas - Pretectal Region](https://portal.brain-map.org/)
• [Human Connectome Project - Brainstem Circuits](https://www.humanconnectome.org/)
• [PMC Article: Oculomotor dysfunction in neurodegenerative diseases](https://pubmed.ncbi.nlm.nih.gov/)

Background

The study of Nucleus Of The Optic Tract (Not) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving Nucleus of the Optic Tract (NOT) Neurons discovered through SciDEX knowledge graph analysis: